Optilite IgA CSF Kit

Method, Nephelometric, Immunoglobulins (g, A, M)

The Binding Site Group Ltd.

The following data is part of a premarket notification filed by The Binding Site Group Ltd. with the FDA for Optilite Iga Csf Kit.

Pre-market Notification Details

Device IDK183151
510k NumberK183151
Device Name:Optilite IgA CSF Kit
ClassificationMethod, Nephelometric, Immunoglobulins (g, A, M)
Applicant The Binding Site Group Ltd. 8 Calthorpe Road Birmingham,  GB B15 1qt
ContactNatasha Verhaak
CorrespondentNatasha Verhaak
The Binding Site Group Ltd. 8 Calthorpe Road Birmingham,  GB B15 1qt
Product CodeCFN  
CFR Regulation Number866.5510 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2018-11-14
Decision Date2019-01-23
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
05051700020190 K183151 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.